[San Antonio, Texas]  AdvaMed 2016, an annual gathering of international medical technology companies,
named Philip W. Faris, CEO and Managing Partner of ProSavant International, as a panelist for the ACCEL
program at the annual AdvaMed 2016 conference. Faris has served on numerous panels with AdvaMed,
offering guidance and assistance to emerging medical device firms.

AdvaMed Accel is the division within AdvaMed dedicated to the needs of smaller medical technology manufacturers.
AdvaMed Accel brings greater focus to issues facing companies with annual U.S. sales of less than $100 million.
It is the vision of AdvaMed Accel to be the leader in advancing medical technology by bolstering the industry’s
emerging and early-growth enterprises – the drivers of disruptive innovation, job creation, and economic expansion.

Mr. Faris has a distinguished track record of building market-leading companies in emerging medical markets
and has successfully performed as CEO for over three decades in start-up, early stage, and high-growth
organizations. He is currently CEO and managing partner at ProSavant International, a strategic consulting firm
for the medical device and biotechnology space. He is also CEO of Minnesota Resuscitation Solutions (MRS),
an emerging medical device firm focused on Heads-Up CPR delivery mechanisms to potentially improve survival
to hospital in cases of cardiac arrest and Chairman of Flashback Technologies, developer of a new monitoring
parameter, Compensatory Reserve Index, to aid in the management of decompensation in severely injured or ill
patients. Faris has also served as Executive Chairman of the Board for Innovative Trauma Care; as a Board
Member, Lead Director and Senior Advisor at Advanced Circulatory Systems, Inc. (now part of ZOLL Medical); on
the Executive Committee of Biomed SA, a non-profit organization promoting the bioscience industry in San Antonio,
Texas; and as a Board Member and Senior Advisor for Vivo Biosciences, an Alabama-based biotechnology
company. Through his career, Faris has acted as CEO and Director at Innovative Trauma Care, Vidacare
Corporation, VidiMedix Corporation, Trestle Corporation, Diatek Corporation and many other medical device,
biotechnology and health care companies.

AdvaMed is an international trade association representing companies that produce the medical devices,
diagnostic products and health information systems that are transforming health care through earlier disease
detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest
to the smallest medical technology innovators and companies. The organization advocates for a legal, regulatory
and economic climate that advances global health care by assuring patients can have access to the benefits
of medical technology.

[San Antonio, Texas] Philip W. Faris, CEO and Managing Partner of ProSavant International, has been named CEO
and member of the Board of Govenors of Minnesota Resuscitation Solutions, LLC (MRS). Based in Minnesota, MRS
is an early stage medical device firm focused on the development and commercialization of Heads-Up CPR delivery mechanisms methods and devices to potentially improve survival to hospital in cases of cardiac arrest. 

Mr. Faris has a distinguished track record of building market-leading companies in emerging medical markets
and has successfully performed as CEO for over three decades in start-up, early stage, and high-growth
organizations. He is currently CEO and managing partner at ProSavant International, a strategic consulting firm for
the medical device and biotechnology space and Chairman of the Board of Flashback Technologies, the developer
of a new monitoring parameter, Compensatory Reserve Index, to aid in the management of decompensation in
severely injured or ill patients. . Faris also served as Executive Chairman of the Board for Innovative Trauma Care;
as a Board Member and Senior Advisor at Advanced Circulatory Systems, Inc. (now part of ZOLL Medical); on the
Executive Committee of Biomed SA, a non-profit organization promoting the bioscience industry in San Antonio,
Texas; and as a Board Member and Senior Advisor for Vivo Biosciences, an Alabama-based biotechnology
company. Through his career, Faris has acted as CEO and Director at Innovative Trauma Care, Vidacare
Corporation, VidiMedix Corporation, Trestle Corporation, Diatek Corporation and many other medical device,
biotechnology and health care companies.

[San Antonio, Texas] ProSavant International client Advanced Circulatory has been sold to ZOLL Medical
Corporation. ProSavant CEO and Managing Partner Philip W. Faris serveds as a Board Member, Lead Director
and Senior Advisor to Advanced Circulatory.

Founded in 1997, Advanced Circulatory Systems’ novel Intrathoracic Pressure Regulation (IPR) therapy platform
has far-reaching implications for multiple medical conditions. This non-invasive therapy can potentially protect
the heart, brain, and other vital organs when blood flow is compromised, giving rescuers, clinicians, and caregivers
the potential to return patients to a full life after critical medical emergencies.

“The acquisition of Advanced Circulatory Systems will broaden ZOLL’s product offerings with additional technologies
designed to improve outcomes from cardiac arrest and other critical conditions," said Jonathan A. Rennert,
President of ZOLL. “This acquisition further demonstrates ZOLL’s commitment to offering the most comprehensive
portfolio of products for acute events where rapid medical intervention is needed.”

“Becoming part of ZOLL provides Advanced Circulatory Systems with an increased infrastructure of clinical and
commercial resources that will enable our technologies to reach a greater number of clinicians and positively
affect more patients’ lives,” said Mike Black, CEO of Advanced Circulatory Systems. “The acquisition gives
Advanced Circulatory Systems the opportunity to become a part of a company with a long history of improving
resuscitation science.”

About Advanced Circulatory Systems
Advanced Circulatory Systems, Inc. manufactures and markets intrathoracic pressure regulation products to help
restore life and improve the quality of life for patients experiencing cardiac arrest, low blood pressure, and head
injury. Advanced Circulatory Systems serves military, emergency medical services, and hospital markets and the
company’s products are sold in over 25 countries worldwide.
For more information, visit http://www.advancedcirculatory.com.

About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software
solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies.
With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation,
therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that
help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical
care. For more information, visit www.zoll.com.

Mr. Faris has a distinguished track record of building market-leading companies in emerging medical markets
and has successfully performed as CEO for over three decades in start-up, early stage, and high-growth
organizations. He is currently CEO and managing partner at ProSavant International, a strategic consulting firm
or the medical device and biotechnology space. Faris also served as Executive Chairman of the Board for Innovative
Trauma Care; on the Executive Committee of Biomed SA, a non-profit organization promoting the bioscience industry
in San Antonio, Texas; and as a Board Member and Senior Advisor for Vivo Biosciences, an Alabama-based
biotechnology company. Through his career, Faris has acted as CEO and Director at Innovative Trauma Care,
Vidacare Corporation, VidiMedix Corporation, Trestle Corporation, Diatek Corporation and many other medical
device, biotechnology and health care companies.

[San Antonio, Texas] Flashback Technologies, Inc. of Boulder, Colorado, has appointed Philip W. Faris
to the company’s Board of Directors. In this role, Faris will provide experienced leadership and guidance
for the company as it secures funding and commercializes its first product, the Compensatory Reserve Index
(CRITM) Monitor.

Faris has a distinguished track record of building market-leading companies in emerging medical markets
and has successfully performed as CEO for over three decades in start-up, early stage,and high-growth
organizations. He is currently CEO and managing partner at ProSavant International, a strategic consulting firm
for the medical device and biotechnology space. He also serves on the Executive Committee of BiomedSA,
a non-profit organization promoting the bioscience industry in San Antonio, Texas, as well as acts as a
Board Member and Senior Advisor for Vivo Biosciences, an Alabama-based biotechnology company.
He also served as a Board Member and Senior Advisor for Advanced Circulatory System, Inc. of Minnesota,
which was recently acquired by ZOLL Medical Corporation. Through his career, Faris has acted as CEO and
Director at Innovative Trauma Care, Vidacare Corporation, VidiMedix Corporation, Trestle Corporation, Diatek
Corporation and many other medical device, biotechnology and health care companies.

Flashback Technologies is a software company whose data analytics based computational engine,
CipherSensor^TM, is being applied to develop products that address unmet needs in medical monitoring.
The company’s first product, the CRI Monitor, measures cardiovascular stability and helps determine a patient’s
intravascular volume status in real time.

[San Antonio, Texas] AdvaMed 2013, an annual gathering of international medical technology companies,
has named Philip W. Faris, CEO and Managing Partner of ProSavant International, as a panelist for the
Entrepreneurship Boot Camp - Business Plan Critical Review and Competition. Faris will evaluate and
provide expert feedback to participating medical technology start-ups presenting their business plans
for evaluation and insight on Monday, September 23 during the annual AdvaMed conference in
Washington, DC. This is the second year that Faris has sat on the panel for this AdvaMed competition.

Mr. Faris has a distinguished track record of building market-leading companies in emerging medical
markets and has successfully performed as CEO for over three decades in start-up, early stage, and
high-growth organizations. He is currently CEO and managing partner at ProSavant International, a strategic
consulting firm for the medical device and biotechnology space. Faris currently serves as Executive Chairman
of the Board for Innovative Trauma Care,  an early-stage medical device firm focused on developing traumatic
injury solutions based in Edmonton, Canada with global commercialization headquarters in San Antonio, Texas;
as a Board Member and Senior Advisor at Advanced Circulatory System, Inc., a Minnesota based perfusion
therapy medical device manufacturer; on the Executive Committee of Biomed SA, a non-profit organization
promoting the bioscience industry in San Antonio, Texas; and as a Board Member and Senior Advisor
for Vivo Biosciences, an Alabama-based biotechnology company. Through his career, Faris has acted
as CEO and Director at Vidacare Corporation, VidiMedix Corporation, Trestle Corporation, Diatek
Corporation and many other medical device, biotechnology and health care companies.

AdvaMed is an international trade association representing companies that produce the medical
devices, diagnostic products and health information systems that are transforming health care through
earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members
range from the largest to the smallest medical technology innovators and companies. The organization
advocates for a legal, regulatory and economic climate that advances global health care by assuring
patients can have access to the benefits of medical technology

[San Antonio, Texas] Philip W. Faris, CEO and Managing Partner of ProSavant International, was a featured
panelist at Texas CEO Magazine’s breakfast meeting discussing San Antonio’s Life Sciences Industry
and how local companies are creating an innovation ecosystem from the inside out. The event, which
was co-hosted by BioMedSA on August 8, also featured Art Markman, Professor of Psychology and Marketing,
University of Texas at Austin; Randy Goldsmith, President & CEO at The Texas Technology Development
Center; Ed Davis, Executive Director, San Antonio Economic Development Corporation; and Paul Castella,
Ph.D., Co-founder, Incyte Venture Partners. 

Mr. Faris has a distinguished track record of building market-leading companies in emerging medical
markets and has successfully performed as CEO for over three decades in start-up, early stage, and
high-growth organizations. He is currently CEO and managing partner at ProSavant International, a strategic
consulting firm for the medical device and biotechnology space. Faris currently serves as Executive Chairman
of the Board for Innovative Trauma Care,  an early-stage medical device firm focused on developing traumatic
injury solutions based in Edmonton, Canada with global commercialization headquarters in San Antonio, Texas;
as a Board Member and Senior Advisor at Advanced Circulatory System, Inc., a Minnesota based perfusion
therapy medical device manufacturer; on the Executive Committee of Biomed SA, a non-profit organization
promoting the bioscience industry in San Antonio, Texas; and as a Board Member and Senior Advisor
for Vivo Biosciences, an Alabama-based biotechnology company. Through his career, Faris has acted
as CEO and Director at Vidacare Corporation, VidiMedix Corporation, Trestle Corporation, Diatek Corporation
and many other medical device, biotechnology and health care companies.

Texas CEO Magazine’s mission is to invigorate business statewide by sharing relevant content, and fostering
a community of Texas business leaders. Texas CEO Magazine readers are business owners, entrepreneurs,
corporate executives, and aspiring CEOs who want to assimilate useful information quickly. They want to stay
current on issues that affect their business environment, companies and workforce. They want to know about
trends and events that present opportunities to expand their business and network of peers within Texas.